Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000012.xml
Endoscopy 2010; 42(6): 503-515
DOI: 10.1055/s-0029-1244208
DOI: 10.1055/s-0029-1244208
Guidelines
© Georg Thieme Verlag KG Stuttgart · New York
European Society of Gastrointestinal Endoscopy (ESGE)Guideline: Prophylaxis of post-ERCP pancreatitis
Further Information
Publication History
submitted 7 January 2010
accepted after revision 15 March 2010
Publication Date:
26 May 2010 (online)
Pancreatitis is the most common complication of endoscopic retrograde cholangiopancreatography (ERCP). Risk factors for post-ERCP pancreatitis (PEP) are both patient-related and procedure-related. Identification of patients at high risk for PEP is important in order to target prophylactic measures. Prevention of PEP includes administration of nonsteroidal inflammatory drugs (NSAIDs), use of specific cannulation techniques, and placement of temporary pancreatic stents. The aim of this guideline commissioned by the European Society of Gastrointestinal Endoscopy (ESGE) is to provide practical, graded, recommendations for the prevention of PEP.
References
- 1 Harbour R, Miller J. A new system for grading recommendations in evidence based guidelines. BMJ. 2001; 323 334-336
- 2 Freeman M L, Nelson D B, Sherman S. et al . Complications of endoscopic biliary sphincterotomy. N Engl J Med. 1996; 335 909-918
- 3 Choi C W, Kang D H, Kim G H. et al . Nafamostat mesylate in the prevention of post-ERCP pancreatitis and risk factors for post-ERCP pancreatitis. Gastrointest Endosc. 2009; 69 e11-e18
- 4 Lee K T, Lee D H, Yoo B M. The prophylactic effect of somatostatin on post-therapeutic endoscopic retrograde cholangiopancreatography pancreatitis. Pancreas. 2008; 37 445-448
- 5 Cotton P B, Lehman G, Vennes J. et al . Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc. 1991; 37 383-393
- 6 Bradley E L. A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, GA, September 11 through 13, 1992: Arch Surg. 1993; 128 586-590
- 7 Testoni P A, Caporuscio S, Bagnolo F, Lella F. Twenty-four-hour serum amylase predicting pancreatic reaction after endoscopic sphincterotomy. Endoscopy. 1999; 31 131-136
- 8 Bretthauer M, Seip B, Aasen S. et al . Carbon dioxide insufflation for more comfortable endoscopic retrograde cholangiopancreatography: a randomized, controlled, double-blind trial. Endoscopy. 2007; 39 58-64
- 9 Andriulli A, Loperfido S, Napolitano G. et al . Incidence rates of post-ERCP complications: a systematic survey of prospective studies. Am J Gastroenterol. 2007; 102 1781-1788
- 10 Masci E, Mariani A, Curioni S, Testoni P A. Risk factors for pancreatitis following endoscopic retrograde cholangiopancreatography: a meta-analysis. Endoscopy. 2003; 35 830-834
- 11 Freeman M L, DiSario J A, Nelson D B. et al . Risk factors for post-ERCP pancreatitis: a prospective, multicenter study. Gastrointest Endosc. 2001; 54 425-434
- 12 Loperfido S, Angelini G, Benedetti G. et al . Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointest Endosc. 1998; 48 1-10
- 13 Masci E, Toti G, Mariani A. et al . Complications of diagnostic and therapeutic ERCP: a prospective multicenter study. Am J Gastroenterol. 2001; 96 417-423
- 14 Williams E J, Taylor S, Fairclough P. et al . Risk factors for complication following ERCP; results of a large-scale, prospective multicenter study. Endoscopy. 2007; 39 793-801
- 15 Harewood G C, Pochron N L, Gostout C J. Prospective, randomized, controlled trial of prophylactic pancreatic stent placement for endoscopic snare excision of the duodenal ampulla. Gastrointest Endosc. 2005; 62 367-370
- 16 Norton I D, Gostout C J, Baron T H. et al . Safety and outcome of endoscopic snare excision of the major duodenal papilla. Gastrointest Endosc. 2002; 56 239-243
- 17 Fazel A, Quadri A, Catalano M F, Meyerson S M, Geenen J E. Does a pancreatic duct stent prevent post-ERCP pancreatitis? A prospective randomized study. Gastrointest Endosc. 2003; 57 291-294
- 18 Smithline A, Silverman W, Rogers D. et al . Effect of prophylactic main pancreatic duct stenting on the incidence of biliary endoscopic sphincterotomy-induced pancreatitis in high-risk patients. Gastrointest Endosc. 1993; 39 652-657
- 19 Tarnasky P R, Palesch Y Y, Cunningham J T. et al . Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction. Gastroenterology. 1998; 115 1518-1524
- 20 Andriulli A, Forlano R, Napolitano G. et al . Pancreatic duct stents in the prophylaxis of pancreatic damage after endoscopic retrograde cholangiopancreatography: a systematic analysis of benefits and associated risks. Digestion. 2007; 75 156-163
- 21 Williams E J, Taylor S, Fairclough P. et al . Are we meeting the standards set for endoscopy? Results of a large-scale prospective survey of endoscopic retrograde cholangio-pancreatograph practice. Gut. 2007; 56 821-829
- 22 Varadarajulu S, Kilgore M L, Wilcox C M, Eloubeidi M A. Relationship among hospital ERCP volume, length of stay, and technical outcomes. Gastrointest Endosc. 2006; 64 338-347
- 23 Allison M C, Ramanaden D N, Fouweather M G, Davis D K, Colin-Jones D G. Provision of ERCP services and training in the United Kingdom. Endoscopy. 2000; 32 693-699
- 24 Hilsden R J, Romagnuolo J, May G R. Patterns of use of endoscopic retrograde cholangiopancreatography in a Canadian province. Can J Gastroenterol. 2004; 18 619-624
- 25
Colton J, Curran C.
Quality indicators, including complications, of ERCP in a community setting: a prospective
study.
Gastrointest Endosc.
2009;
70
457-467
MissingFormLabel
- 26 Rabenstein T, Roggenbuck S, Framke B. et al . Complications of endoscopic sphincterotomy: can heparin prevent acute pancreatitis after ERCP?. Gastrointest Endosc. 2002; 55 476-483
- 27 Gottlieb K, Sherman S, Pezzi J, Esber E, Lehman G A. Early recognition of post-ERCP pancreatitis by clinical assessment and serum pancreatic enzymes. Am J Gastroenterol. 1996; 91 1553-1557
- 28 Testoni P A, Bagnolo F. Pain at 24 hours associated with amylase levels greater than 5 times the upper normal limit as the most reliable indicator of post-ERCP pancreatitis. Gastrointest Endosc. 2001; 53 33-39
- 29 Kapetanos D, Kokozidis G, Kinigopoulou P. et al . The value of serum amylase and elastase measurements in the prediction of post-ERCP acute pancreatitis. Hepato-Gastroenterol. 2007; 54 556-560
- 30 Thomas P R, Sengupta S. Prediction of pancreatitis following endoscopic retrograde cholangiopancreatography by the 4-h post procedure amylase level. J Gastroenterol Hepatol. 2001; 16 923-926
- 31 Ito K, Fujita N, Noda Y. et al . Relationship between post-ERCP pancreatitis and the change of serum amylase level after the procedure. World J Gastroenterol. 2007; 13 3855-3860
- 32 Dai H-F, Wang X-W, Zhao K. Role of nonsteroidal anti-inflammatory drugs in the prevention of post-ERCP pancreatitis: a meta-analysis. Hepatobiliary Pancreat Dis Int. 2009; 8 11-16
- 33 Elmunzer B, Waljee A, Elta G. et al . A meta-analysis of rectal NSAIDs in the prevention of post-ERCP pancreatitis. Gut. 2008; 57 1262
- 34 Zheng M-H, Xia H, Chen Y-P. Rectal administration of NSAIDs in the prevention of post-ERCP pancreatitis: a complementary meta-analysis. Gut. 2008; 57 1632
- 35 Bang U C, Nojgaard C, Andersen P K, Matzen P. Meta-analysis: Nitroglycerin for prevention of post-ERCP pancreatitis. Aliment Pharmacol Ther. 2009; 29 1078-1085
- 36 Shao L M, Chen Q Y, Chen M Y, Cai J T. Nitroglycerin in the prevention of post-ERCP pancreatitis: a meta-analysis. Dig Dis Sci. 2010; 55 1-7
- 37 Raty S, Sand J, Pulkkinen M, Matikainen M, Nordback I. Post-ERCP pancreatitis: reduction by routine antibiotics. J Gastrointest Surg. 2001; 5 339-345; discussion 345
- 38 Andriulli A, Clemente R, Solmi L. et al . Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: a multicenter, placebo-controlled, randomized clinical trial. Gastrointest Endosc. 2002; 56 488-495
- 39 Andriulli A, Solmi L, Loperfido S. et al . Prophylaxis of ERCP-related pancreatitis: a randomized, controlled trial of somatostatin and gabexate mesylate. Clin Gastroenterol Hepatol. 2004; 2 713-718
- 40 Arvanitidis D, Anagnostopoulos G K, Giannopoulos D. et al . Can somatostatin prevent post-ERCP pancreatitis? Results of a randomized controlled trial. J Gastroenterol Hepatol. 2004; 19 278-282
- 41 Benvenutti S, Zancanella L, Piazzi L. et al . Prevention of post-ERCP pancreatitis with somatostatin versus gabexate mesylate: A randomized placebo controlled multicenter study. Dig Liv Dis. 2006; 38 S15
- 42 Bordas J M, Toledo-Pimentel V, Llach J. et al . Effects of bolus somatostatin in preventing pancreatitis after endoscopic pancreatography: results of a randomized study. Gastrointest Endosc. 1998; 47 230-234
- 43 Persson B, Slezak P, Efendic S, Haggmark A. Can somatostatin prevent injection pancreatitis after ERCP?. Hepatogastroenterology. 1992; 39 259-261
- 44 Poon R T, Yeung C, Liu C L. et al . Intravenous bolus somatostatin after diagnostic cholangiopancreatography reduces the incidence of pancreatitis associated with therapeutic endoscopic retrograde cholangiopancreatography procedures: a randomised controlled trial. Gut. 2003; 52 1768-1773
- 45 Poon R T, Yeung C, Lo C M. et al . Prophylactic effect of somatostatin on post-ERCP pancreatitis: a randomized controlled trial. Gastrointest Endosc. 1999; 49 593-598
- 46 Saari A, Kivilaakso E, Schroder T. The influence of somatostatin on pancreatic irritation after pancreatography. An experimental and clinical study. Surg Res Comm. 1988; 2 271-278
- 47 Arcidiacono R, Gambitta P, Rossi A. et al . The use of a long-acting somatostatin analogue (octreotide) for prophylaxis of acute pancreatitis after endoscopic sphincterotomy. Endoscopy. 1994; 26 715-718
- 48 Duvnjak M, Supanc V, Simicevic V N. et al . Use of octreotide-acetate in preventing pancreatitis-like changes following therapeutic endoscopic retrograde cholangiopancreatography. Acta Med Croatica. 1999; 53 115-118
- 49 Hardt P D, Kress O, Fadgyas T. et al . Octreotide in the prevention of pancreatic damage induced by endoscopic sphincterotomy. Eur J Med Res. 2000; 5 165-170
- 50 Li Z S, Pan X, Zhang W J. et al . Effect of octreotide administration in the prophylaxis of post-ERCP pancreatitis and hyperamylasemia: A multicenter, placebo-controlled, randomized clinical trial. Am J Gastroenterol. 2007; 102 46-51
- 51 Manolakopoulos S, Avgerinos A, Vlachogiannakos J. et al . Octreotide versus hydrocortisone versus placebo in the prevention of post-ERCP pancreatitis: a multicenter randomized controlled trial. Gastrointest Endosc. 2002; 55 470-475
- 52 Sternlieb J M, Aronchick C A, Retig J N. et al . A multicenter, randomized, controlled trial to evaluate the effect of prophylactic octreotide on ERCP-induced pancreatitis. Am J Gastroenterol. 1992; 87 1561-1566
- 53 Testoni P A, Bagnolo F, Andriulli A. et al . Octreotide 24-h prophylaxis in patients at high risk for post-ERCP pancreatitis: results of a multicenter, randomized, controlled trial. Aliment Pharmacol Ther. 2001; 15 965-972
- 54 Thomopoulos K C, Pagoni N A, Vagenas K A. et al . Twenty-four hour prophylaxis with increased dosage of octreotide reduces the incidence of post-ERCP pancreatitis. Gastrointest Endosc. 2006; 64 726-731
- 55 Cavallini G, Tittobello A, Frulloni L. et al . Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. Gabexate in digestive endoscopy – Italian Group. N Engl J Med. 1996; 335 919-923
- 56 Manes G, Ardizzone S, Lombardi G. et al . Efficacy of postprocedure administration of gabexate mesylate in the prevention of post-ERCP pancreatitis: a randomized, controlled, multicenter study. Gastrointest Endosc. 2007; 65 982-987
- 57 Xiong G S, Wu S M, Zhang X W, Ge Z Z. Clinical trial of gabexate in the prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis. Braz J Med Biol Res. 2006; 39 85-90
- 58 Fujishiro H, Adachi K, Imaoka T. et al . Ulinastatin shows preventive effect on post-endoscopic retrograde cholangiopancreatography pancreatitis in a multicenter prospective randomized study. J Gastroenterol Hepatol. 2006; 21 1065-1069
- 59 Tsujino T, Komatsu Y, Isayama H. et al . Ulinastatin for pancreatitis after endoscopic retrograde cholangiopancreatography: a randomized, controlled trial. Clin Gastroenterol Hepatol. 2005; 3 376-383
- 60 Ueki T, Otani K, Kawamoto K. et al . Comparison between ulinastatin and gabexate mesylate for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a prospective, randomized trial. J Gastroenterol. 2007; 42 161-167
- 61 Yoo J W, Ryu J K, Lee S H. et al . Preventive effects of ulinastatin on post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients: a prospective, randomized, placebo-controlled trial. Pancreas. 2008; 37 366-370
- 62 Bai Y, Gao J, Shi X, Zou D, Li Z. Prophylactic corticosteroids do not prevent post-ERCP pancreatitis: a meta-analysis of randomized controlled trials. Pancreatology. 2008; 8 504-509
- 63 Zheng M, Bai J, Yuan B. et al . Meta-analysis of prophylactic corticosteroid use in post-ERCP pancreatitis. BMC Gastroenterol. 2008; 8 6
- 64 Gorelick A, Barnett J, Chey W, Anderson M, Elta G. Botulinum toxin injection after biliary sphincterotomy. Endoscopy. 2004; 36 170-173
- 65 Matsushita M, Takakuwa H, Shimeno N. et al . Epinephrine sprayed on the papilla for prevention of post-ERCP pancreatitis. J Gastroenterol. 2009; 44 71-75
- 66 Schwartz J J, Lew R J, Ahmad N A. et al . The effect of lidocaine sprayed on the major duodenal papilla on the frequency of post-ERCP pancreatitis. Gastrointest Endosc. 2004; 59 179-184
- 67 Prat F, Amaris J, Ducot B. et al . Nifedipine for prevention of post-ERCP pancreatitis: a prospective, double-blind randomized study. Gastrointest Endosc. 2002; 56 202-208
- 68 Sand J, Nordback I. Prospective randomized trial of the effect of nifedipine on pancreatic irritation after endoscopic retrograde cholangiopancreatography. Digestion. 1993; 54 105-111
- 69 Bai Y, Gao J, Zhang W, Zou D, Li Z. Meta-analysis: allopurinol in the prevention of postendoscopic retrograde cholangiopancreatography pancreatitis. Aliment Pharmacol Ther. 2008; 28 557-564
- 70 Zheng M, Chen Y, Bai J. et al . Meta-analysis of prophylactic allopurinol use in post-endoscopic retrograde cholangiopancreatography pancreatitis. Pancreas. 2008; 37 247-253
- 71 Andriulli A, Annese V. Risk of post-endoscopic retrograde cholangiopancreatography pancreatitis and ways to prevent it: old myths, a current need? The case of allopurinol. Clin Gastroenterol Hepatol. 2008; 6 374-376
- 72 Katsinelos P, Kountouras J, Paroutoglou G. et al . Intravenous N-acetylcysteine does not prevent post-ERCP pancreatitis. Gastrointest Endosc. 2005; 62 105-111
- 73 Milewski J, Rydzewska G, Degowska M, Kierzkiewicz M, Rydzewski A. N-acetylcysteine does not prevent post-endoscopic retrograde cholangiopancreatography hyperamylasemia and acute pancreatitis. World J Gastroenterol. 2006; 12 3751-3755
- 74 Lavy A, Karban A, Suissa A. et al . Natural beta-carotene for the prevention of post-ERCP pancreatitis. Pancreas. 2004; 29 e45-e50
- 75 Barkay O, Niv E, Santo E. et al . Low-dose heparin for the prevention of post-ERCP pancreatitis: a randomized placebo-controlled trial. Surg Endosc. 2008; 22 1971-1976
- 76 Rabenstein T, Fischer B, Wiessner V. et al . Low-molecular-weight heparin does not prevent acute post-ERCP pancreatitis. Gastrointest Endosc. 2004; 59 606-613
- 77 Deviere J, Le Moine O, Van Laethem J L. et al . Interleukin 10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography. Gastroenterology. 2001; 120 498-505
- 78 Dumot J A, Conwell D L, Zuccaro Jr G. et al . A randomized, double blind study of interleukin 10 for the prevention of ERCP-induced pancreatitis. Am J Gastroenterol. 2001; 96 2098-2102
- 79 Sherman S, Cheng C L, Costamagna G. et al . Efficacy of recombinant human interleukin-10 in prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis in subjects with increased risk. Pancreas. 2009; 38 267-274
- 80 Sherman S, Cheng C-L, Costamagna G. et al . Efficacy of recombinant human interleukin-10 in prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis in subjects with increased risk. Pancreas. 2009; 38 267-274
- 81 Kapetanos D, Kokozidis G, Christodoulou D. et al . A randomized controlled trial of pentoxifylline for the prevention of post-ERCP pancreatitis. Gastrointest Endosc. 2007; 66 513-518
- 82 Sherman S, Alazmi W M, Lehman G A. et al . Evaluation of recombinant platelet-activating factor acetylhydrolase for reducing the incidence and severity of post-ERCP acute pancreatitis. Gastrointest Endosc. 2009; 69 462-472
- 83 van Westerloo D J, Rauws E A, Hommes D. et al . Pre-ERCP infusion of semapimod, a mitogen-activated protein kinases inhibitor, lowers post-ERCP hyperamylasemia but not pancreatitis incidence. Gastrointest Endosc. 2008; 68 246-254
- 84 Terruzzi V, Radaelli F, Meucci G, Minoli G. Is the supine position as safe and effective as the prone position for endoscopic retrograde cholangiopancreatography? A prospective randomized study. Endoscopy. 2005; 37 1211-1214
- 85 Tringali A, Mutignani M, Milano A, Perri V, Costamagna G. No difference between supine and prone position for ERCP in conscious sedated patients: a prospective randomized study. Endoscopy. 2008; 40 93-97
- 86 Vandervoort J, Soetikno R M, Tham T CK. et al . Risk factors for complications after performance of ERCP. Gastrointest Endosc. 2002; 56 652-656
- 87 Cheon Y K, Cho K B, Watkins J L. et al . Frequency and severity of post-ERCP pancreatitis correlated with extent of pancreatic ductal opacification. Gastrointest Endosc. 2007; 65 385-393
- 88 George S, Kulkarni A A, Stevens G, Forsmark C E, Draganov P. Role of osmolality of contrast media in the development of post-ERCP pancreatitis: a meta-analysis. Dig Dis Sci. 2004; 49 503-508
- 89 Keswani R, Hovis R, Edmunowicz S. et al . Carbon dioxide (CO2) insufflation during ERCP for the reduction of post-procedure pain: preliminary results of a randomized, double-blind controlled trial. Gastrointest Endosc. 2008; 67 AB107
- 90 Maple J T, Keswani R N, Hovis R M. et al . Carbon dioxide insufflation during ERCP for reduction of postprocedure pain: a randomized, double-blind, controlled trial. Gastrointest Endosc. 2009; 70 278-283
- 91 Cennamo V, Fuccio L, Zagari R M. et al . Can a wire-guided cannulation technique increase bile duct cannulation rate and prevent post-ERCP pancreatitis?: A meta-analysis of randomized controlled trials. Am J Gastroenterol. 2009; 104 2343-2350
- 92 Choudhary A, Puli S, Ibdah J, Bechtold M. Guidewire use for prevention of post ERCP pancreatitis: a meta-analysis of randomized controlled trials. Gastrointest Endosc. 2009; 69 AB305
- 93 Madhoun M, Te C, Stoner J, Maple J. Does wire-guided cannulation prevent post-ERCP pancreatitis? A meta-analysis. Gastrointest Endosc. 2009; 69 AB132
- 94 Cheung J, Tsoi K K, Quan W-L, Lau J YW, Sung J JY. Guidewire versus conventional contrast cannulation of the common bile duct for the prevention of post-ERCP pancreatitis: a systematic review and meta-analysis. Gastrointest Endosc. 2009; 70 1211-1219
- 95 Verma D, Kapadia A, Adler D G. Pure versus mixed electrosurgical current for endoscopic biliary sphincterotomy: a meta-analysis of adverse outcomes. Gastrointest Endosc. 2007; 66 283-290
- 96 Herreros de Tejada A, Calleja J L, Díaz G. et al . Double-guidewire technique for difficult bile duct cannulation: a multicenter randomized, controlled trial. Gastrointest Endosc. 2009; 70 700-709
- 97 Maeda S, Hayashi H, Hosokawa O. et al . Prospective randomized pilot trial of selective biliary cannulation using pancreatic guide-wire placement. Endoscopy. 2003; 35 721-724
- 98 Ito K, Fujita N, Noda Y. et al . Can pancreatic duct stenting prevent post-ERCP pancreatitis in patients who undergo pancreatic guidewire placement for achieving selective biliary cannulation? A prospective randomized controlled trial. Endoscopy. 2008; 40 (Suppl 1) A17
- 99 Nguyen-Tang T, Dumonceau J M. Double-guidewire technique for difficult bile duct cannulation: why not insert a prophylactic pancreatic stent?. Gastrointest. Endosc 2010; in press
- 100 Iqbal S, Sharma P, Shah S. Role of double guide wire cannulation during ERCP. Gastrointest Endosc. 2008; 67 AB158
- 101 Ito K, Fujita N, Noda Y. et al . Pancreatic guidewire placement for achieving selective biliary cannulation during endoscopic retrograde cholangio-pancreatography. World J Gastroenterol. 2008; 14 5595-5600; discussion 5599
- 102 Patel S, Torres V, Gross G. The early use of the double-wire technique to facilitate difficult biliary cannulation and its impact on post-ERCP pancreatitis. Gastrointest Endosc. 2009; 69 AB159
- 103 Gyökeres T, Duhl J, Varsányi M. et al . Double guide wire placement for endoscopic pancreaticobiliary procedures. Endoscopy. 2003; 35 95-96
- 104 Cennamo V, Fuccio L, Repici A. et al . Timing of precut procedure does not influence success rate and complications of ERCP procedure: a prospective randomized comparative study. Gastrointest Endosc. 2009; 69 473-479
- 105 Wang P, Li Z-S, Liu F. et al . Risk factors for ERCP-related complications: a prospective multicenter study. Am J Gastroenterol. 2009; 104 31-40
- 106 Akaraviputh T, Lohsiriwat V, Swangsri J. et al . The learning curve for safety and success of precut sphincterotomy for therapeutic ERCP: a single endoscopist’s experience. Endoscopy. 2008; 40 513-516
- 107 Fukatsu H, Kawamoto H, Harada R. et al . Quantitative assessment of technical proficiency in performing needle-knife precut papillotomy. Surg Endosc. 2009; 23 2066-2072
- 108 Harewood G C, Baron T H. An assessment of the learning curve for precut biliary sphincterotomy. Am J Gastroenterol. 2002; 97 1708-1712
- 109 Manes G, Di Giorgio P, Repici A. et al . An analysis of the factors associated with the development of complications in patients undergoing precut sphincterotomy: a prospective, controlled, randomized, multicenter study. Am J Gastroenterol. 2009; 104 2412-2417
- 110 de Weerth A, Seitz U, Zhong Y. et al . Primary precutting versus conventional over-the-wire sphincterotomy for bile duct access: a prospective randomized study. Endoscopy. 2006; 38 1235-1240
- 111 Tang S-J, Haber G B, Kortan P. et al . Precut papillotomy versus persistence in difficult biliary cannulation: a prospective randomized trial. Endoscopy. 2005; 37 58-65
- 112 Yasuda I, Tomita E, Enya M, Kato T, Moriwaki H. Can endoscopic papillary balloon dilation really preserve sphincter of Oddi function?. Gut. 2001; 49 686-691
- 113 Baron T H, Harewood G C. Endoscopic balloon dilation of the biliary sphincter compared to endoscopic biliary sphincterotomy for removal of common bile duct stones during ERCP: a metaanalysis of randomized, controlled trials. Am J Gastroenterol. 2004; 99 1455-1460
- 114 Weinberg B M, Shindy W, Lo S. Endoscopic balloon sphincter dilation (sphincteroplasty) versus sphincterotomy for common bile duct stones. Cochrane Database Syst Rev. 2006; CD004890
- 115 DiSario J A, Freeman M L, Bjorkman D J. et al . Endoscopic balloon dilation compared with sphincterotomy for extraction of bile duct stones. Gastroenterology. 2004; 127 1291-1299
- 116 Attasaranya S, Cheon Y, Vittal H. et al . Large-diameter biliary orifice balloon dilation to aid in endoscopic bile duct stone removal: a multicenter series. Gastrointest Endosc. 2008; 67 1046-1052
- 117 Ersoz G, Tekesin O, Ozutemiz A O, Gunsar F. Biliary sphincterotomy plus dilation with a large balloon for bile duct stones that are difficult to extract. Gastrointest Endosc. 2003; 57 156-159
- 118 Maydeo A, Bhandari S. Balloon sphincteroplasty for removing difficult bile duct stones. Endoscopy. 2007; 39 958-961
- 119 Minami A, Hirose S, Nomoto T, Hayakawa S. Small sphincterotomy combined with papillary dilation with large balloon permits retrieval of large stones without mechanical lithotripsy. World J Gastroenterol. 2007; 13 2179-2182
- 120 Misra S P, Dwivedi M. Large-diameter balloon dilation after endoscopic sphincterotomy for removal of difficult bile duct stones. Endoscopy. 2008; 40 209-213
- 121 Heo J H, Kang D H, Jung H J. et al . Endoscopic sphincterotomy plus large-balloon dilation versus endoscopic sphincterotomy for removal of bile-duct stones. Gastrointest Endosc. 2007; 66 720-726; quiz 768, 771
- 122 Kawamoto M, Geenen J, Omari T. et al . Sleeve sphincter of Oddi (SO) manometry: a new method for characterizing the motility of the sphincter of Oddi. J Hepatobiliary Pancreat Surg. 2008; 15 391-396
- 123 Frenz M B, Wehrmann T. Solid state biliary manometry catheter: impact on diagnosis and post-study pancreatitis. Curr Gastroenterol Rep. 2007; 9 171-174
- 124 Craig A G, Omari T, Lingenfelser T. et al . Development of a sleeve sensor for measurement of sphincter of Oddi motility. Endoscopy. 2001; 33 651-657
- 125 Sherman S, Troiano F P, Hawes R H, Lehman G A. Sphincter of Oddi manometry: decreased risk of clinical pancreatitis with use of a modified aspirating catheter. Gastrointest Endosc. 1990; 36 462-466
- 126 Draganov P, Kowalczyk L, Forsmark C. Prospective trial comparing solid-state catheter and water-perfusion triple-lumen catheter for sphincter of Oddi manometry done at the time of ERCP. Gastrointest Endosc. 2009; 70 92-95
- 127 Wehrmann T, Stergiou N, Schmitt T, Dietrich C F, Seifert H. Reduced risk for pancreatitis after endoscopic microtransducer manometry of the sphincter of Oddi: a randomized comparison with the perfusion manometry technique. Endoscopy. 2003; 35 472-477
- 128 Sherman S, Hawes R H, Troiano F P, Lehman G A. Pancreatitis following bile duct sphincter of Oddi manometry: utility of the aspirating catheter. Gastrointest Endosc. 1992; 38 347-350
- 129 Singh P, Das A, Isenberg G. et al . Does prophylactic pancreatic stent placement reduce the risk of post-ERCP acute pancreatitis? A meta-analysis of controlled trials. Gastrointest Endosc. 2004; 60 544-550
- 130 Sofuni A, Maguchi H, Itoi T. et al . Prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis by an endoscopic pancreatic spontaneous dislodgement stent. Clin Gastroenterol Hepatol. 2007; 5 1339-1346
- 131 Chahal P, Tarnasky P, Petersen B. et al . Short 5Fr vs long 3Fr pancreatic stents in patients at high risk for post- endoscopic cholangiopancreatography pancreatitis. Clin Gastroenterol Hepatol. 2009; 7 834-839
- 132 Fehmi S MA, Schoenfeld P S, Scheiman J M. et al . 5 Fr prophylactic pancreatic stents are easier to place and require fewer guide wires than 3 Fr stents. Gastrointest Endosc. 2008; 67 AB328-AB329
- 133
Smith M T, Sherman S, Ikenberry S O, Hawes R H, Lehman G A.
Alterations in pancreatic ductal morphology following polyethylene pancreatic stent
therapy.
Gastrointest Endosc.
1996;
44
268-275
MissingFormLabel
- 134 Das A, Singh P, Sivak M V, Chak A. Pancreatic-stent placement for prevention of post-ERCP pancreatitis: a cost-effectiveness analysis. Gastrointest Endosc. 2007; 65 960-968
- 135 Freeman M L, Overby C, Qi D. Pancreatic stent insertion: consequences of failure and results of a modified technique to maximize success. Gastrointest Endosc. 2004; 59 8-14
- 136 Brackbill S, Young S, Schoenfeld P, Elta G. A survey of physician practices on prophylactic pancreatic stents. Gastrointest Endosc. 2006; 64 45-52
- 137 Dumonceau J M, Rigaux J, Kahaleh M. et al . Prophylaxis of post-ERCP pancreatitis: a practice survey. Gastrointest Endosc. 2010; 71 934-939
J.-M. DumonceauMD, PhD
Division of Gastroenterology and Hepatology
Geneva University Hospitals
rue Micheli-du-Crest 24
1205 Geneva
Switzerland
Fax: +41-22-3729366
Email: jmdumonceau@hotmail.com